With more than 17 years of pharmaceutical experience spanning the EU and international markets, I am a commercial strategy leader who has built and scaled high-performing teams and driven successful global brand strategies in rare diseases, epilepsy, and high-cost therapies. My leadership spans from launch planning to portfolio optimization, enabling sustainable access and patient impact in complex markets.

• Established new therapeutic area units and led rare disease launches recognized globally for their success
• Delivered €1.5B+ peak sales through lifecycle planning, loss-of-exclusivity management, and generics integration
• Developed AI-driven omnichannel strategies tailored to stakeholders across 27 countries
• Led two pan-European launches across diverse ecosystems, delivering best-in-class results and setting benchmarks for execution excellence
• Proven ability to align global brand direction with local market realities to overcome access hurdles
• Trusted partner for executive teams seeking market clarity, digital transformation, and launch excellence